EU Clinical Trial Information System (CTIS)

Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.

I searched for some studies on AstraZeneca Clinical Trials, and found these studies that may also be of interest to you.
Here is the link to my search results

Official Title

The purpose of this study is to confirm the safety profile such as the frequency of serious adverse events or any unexpected adverse events and overall efficacy of Faslodex for long term treatment in daily clinical practice.

Faslodex Specific Clinical Experience Investigation

NCT ID

Therapeutic Area

D6997C00008Fulvestrant_Specific_Clinical_Experience_Investigation_Protocol_redacted_23February2016

Faslodex Specific Clinical Experience Investigation

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Documents available

CSR_Synopsis_D6997C00008

D6997C00008Fulvestrant_Specific_Clinical_Experience_Investigation_Protocol_redacted_23February2016

Trial Results Summaries

Contacts

Contact

Investigators

Principal Investigator